The wire › SEC Form 8-K
TITAN PHARMACEUTICALS INC TTNP
Filed with the SEC on Apr 1, 2025. Reported event date Mar 26, 2025.
- Business address
- San Francisco, CA
- State
- California
- Incorporated in
- Delaware
- Industry
- Manufacturing (SIC 2836)
- SEC CIK
- 910267
- Accession number
- 0001829126-25-002284
Items reported in this filing
- Item 1.01 Entry into a Material Definitive Agreement
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
- Item 3.02 Unregistered Sales of Equity Securities
- Item 5.02 Departure or Appointment of Directors or Officers; Compensatory Arrangements
- Item 9.01 Financial Statements and Exhibits
Other entries on the wire for this company
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing